Your help is needed to improve healthcare for people living with spondyloarthritis. Too often we face healthcare professionals with little or no knowledge of ankylosing spondylitis and related diseases. Too many of us could have been…
Listen as coinvestigator and rheumatologist Dr. Andrea Rubbert-Roth reviews this Phase 3 trial of a JAKi in patients with giant cell arteritis. Dr. Rubbert-Roth discusses…
The FDA has approved the Janus kinase inhibitor upadacitinib for the treatment of giant cell arteritis in adults, the first such approval in the disease…
The Health Advocates A podcast that breaks down major health news of the week to help you make sense of it all.
lting disability in cLBP. This article aims to examine the associations of back function with FAB. Methods: This study presents data from a cohort study…
Biomarkers in blood and plasma can be used to predict rheumatoid arthritis-associated interstitial lung disease more accurately than clinical risk factors alone, suggesting potential new…
DESTIN, Fla. — Inflammatory arthritis as a result of immune checkpoint cancer therapy remains a pressing challenge for patients and rheumatologists alike, according to a…
al nerve can give rise to radicular symptoms and back pain. LFS can impede function and induce atrophy of the segmentally innervated multifidus muscle. Materials…
📢 EULAR proudly launches EULAR Rheumatology Open (ERO), a new open-access journal hosted by Elsevier, dedicated to advancing global rheumatology research. …
Pulsed Nd:YAG laser therapy accelerates fracture healing in a rat femoral osteotomy model
Register for free learning The workup and management of patients with Giant Cell Arteritis In this upcoming webinar on vasculitis, Christina Ponte, Christian Dejaco, and…
